Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Futura has 'transformational year' in 2023

(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration". Futura stated it had successfully executed its initial market launches of Eroxon, an over-the-counter topical treatment for erectile dysfunction, and noted that the first meaningful revenues had been generated from product sales, with the broader success of the UK launch being a catalyst for "significant strategic progress" across multiple markets.

The AIM-listed group also pointed out that it now has approval for its erectile dysfunction gel in the US, as well as a blue-chip partner in the form of Haleon.

In a note to clients, analysts at Liberum said: "Aside from a little timing difference that has already reversed out, Futura is progressing in line with expectations and today's trading update is a timely reminder of how much progress the company has made and how little credit it has been given for this progress."

As of 1005 GMT, Futura shares had surged 37.18% to 38.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Chipmaker TSMC lifts sales guidance as AI boom continues
(Sharecast News) - Apple and Nvidia supplier TSMC lifted its sales guidance for the full year on Thursday as demand for its chips continues to be supported by the ongoing AI boom.
Craneware full-year revenue set to top expectations
(Sharecast News) - US healthcare management and support specialist Craneware reported a strong full-year sales performance in an update on Thursday, driven by ongoing investment in the Trisus platform and successful partner programmes, resulting in significant returns for its US healthcare provider customers.
Meta reportedly in talks to buy stake in Ray-Ban maker EssilorLuxottica
(Sharecast News) - Facebook parent company Meta is reportedly in discussions to buy a 5% stake in Italian-French eyewear maker EssilorLuxottica as the social-media giant looks to deepen its ties with the company that makes its Ray-Ban Meta smart glasses.
Midwich revenue rises, earnings fall in first half
(Sharecast News) - Specialist audio-visual distributor Midwich Group reported a robust first-half revenue performance on Thursday, but a fall in earnings amid challenging market conditions.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.